Article Details
Retrieved on: 2022-11-29 01:15:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus docetaxel with Bristol Myers Squibb.
Article found on: www.labiotech.eu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here